This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sign In   |   Register
Themed Short Track July-August 2020
Share |

Introducing Themed Short Tracks

In SHORT TRACKS we collect 2-4 recent lectures from EAS congresses or courses, putting them together to provide up-to-date perspectives on a given current topic.

This month’s Short Track topic is “The need of lowering LDL-cholesterol as the primary culprit of atherosclerotic vascular events”. Under this headline, we have selected three presentations given at the EAS Congress in Maastricht 2019.

                 To the SHORT TRACK The need of lowering LDL-cholesterol as the primary culprit of atherosclerotic vascular events >>

These presentations are Open Access for members and non-members.                                                                          

EAS ACADEMY- The need of lowering LDL-cholesterol as the primary culprit of atherosclerotic vascular events

The three talks by prominent experts selected for this edition of EAS Themed Short Track will update you on the evidence supporting the need of lowering LDL-cholesterol as the primary culprit of atherosclerotic vascular events. The lectures, also, summarize rationale for bringing cholesterol levels further down as recommended by the most recent guidelines.
Finally, in an impressive review of actual development of lipid lowering therapies you will learn, which new directions will be offered to clinicians in the field to pursue the concepts of personalised medicine in ASCVD prevention and treatment.

 

The genetic evidence for inhibiting the cholesterol synthesis pathway to control LDL cholesterol. 

By Professor Brian Ference, Centre for Naturally Randomized Trials, University of Cambridge, United Kingdom.

To the presentation >>


 

 

 

The criticality of LDL goal attainment.

By Professor Maciej Banach, Polish Mother's Memorial Hospital - Research Institute (PMMHRI), University of Zielona Gora, Medical University of Lodz, Poland.

To the presentation >>


 

 

New lipid drugs: Is LDL done, ready for new targets?

By Professor Eric Stroes, Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands.

To the presentation >>
 

 

Membership Software Powered by YourMembership  ::  Legal